JP2017052962A5 - - Google Patents

Download PDF

Info

Publication number
JP2017052962A5
JP2017052962A5 JP2016214773A JP2016214773A JP2017052962A5 JP 2017052962 A5 JP2017052962 A5 JP 2017052962A5 JP 2016214773 A JP2016214773 A JP 2016214773A JP 2016214773 A JP2016214773 A JP 2016214773A JP 2017052962 A5 JP2017052962 A5 JP 2017052962A5
Authority
JP
Japan
Prior art keywords
group
aminooxy
oligosaccharide
reactive group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016214773A
Other languages
English (en)
Japanese (ja)
Other versions
JP6309592B2 (ja
JP2017052962A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017052962A publication Critical patent/JP2017052962A/ja
Publication of JP2017052962A5 publication Critical patent/JP2017052962A5/ja
Application granted granted Critical
Publication of JP6309592B2 publication Critical patent/JP6309592B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016214773A 2007-01-18 2016-11-02 アミノオキシ基を含むオリゴ糖およびその複合体 Active JP6309592B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88547107P 2007-01-18 2007-01-18
US60/885,471 2007-01-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014204593A Division JP6039625B2 (ja) 2007-01-18 2014-10-03 アミノオキシ基を含むオリゴ糖およびその複合体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018044959A Division JP2018109194A (ja) 2007-01-18 2018-03-13 アミノオキシ基を含むオリゴ糖およびその複合体

Publications (3)

Publication Number Publication Date
JP2017052962A JP2017052962A (ja) 2017-03-16
JP2017052962A5 true JP2017052962A5 (enExample) 2017-06-08
JP6309592B2 JP6309592B2 (ja) 2018-04-11

Family

ID=39473250

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2009546533A Active JP5999867B2 (ja) 2007-01-18 2008-01-18 アミノオキシ基を含むオリゴ糖およびその複合体
JP2014204593A Active JP6039625B2 (ja) 2007-01-18 2014-10-03 アミノオキシ基を含むオリゴ糖およびその複合体
JP2016214773A Active JP6309592B2 (ja) 2007-01-18 2016-11-02 アミノオキシ基を含むオリゴ糖およびその複合体
JP2018044959A Pending JP2018109194A (ja) 2007-01-18 2018-03-13 アミノオキシ基を含むオリゴ糖およびその複合体
JP2020134331A Pending JP2020185011A (ja) 2007-01-18 2020-08-07 アミノオキシ基を含むオリゴ糖およびその複合体
JP2022113593A Pending JP2022137232A (ja) 2007-01-18 2022-07-15 アミノオキシ基を含むオリゴ糖およびその複合体
JP2024207922A Pending JP2025029023A (ja) 2007-01-18 2024-11-29 アミノオキシ基を含むオリゴ糖およびその複合体

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2009546533A Active JP5999867B2 (ja) 2007-01-18 2008-01-18 アミノオキシ基を含むオリゴ糖およびその複合体
JP2014204593A Active JP6039625B2 (ja) 2007-01-18 2014-10-03 アミノオキシ基を含むオリゴ糖およびその複合体

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018044959A Pending JP2018109194A (ja) 2007-01-18 2018-03-13 アミノオキシ基を含むオリゴ糖およびその複合体
JP2020134331A Pending JP2020185011A (ja) 2007-01-18 2020-08-07 アミノオキシ基を含むオリゴ糖およびその複合体
JP2022113593A Pending JP2022137232A (ja) 2007-01-18 2022-07-15 アミノオキシ基を含むオリゴ糖およびその複合体
JP2024207922A Pending JP2025029023A (ja) 2007-01-18 2024-11-29 アミノオキシ基を含むオリゴ糖およびその複合体

Country Status (21)

Country Link
US (6) US8759501B2 (enExample)
EP (5) EP3597655B1 (enExample)
JP (7) JP5999867B2 (enExample)
CN (2) CN102978185B (enExample)
CA (1) CA2675968C (enExample)
CY (2) CY1119954T1 (enExample)
DK (3) DK2121713T3 (enExample)
ES (3) ES2656314T3 (enExample)
FI (1) FIC20220047I1 (enExample)
FR (1) FR22C1061I2 (enExample)
HR (3) HRP20130744T1 (enExample)
HU (3) HUE036140T2 (enExample)
IL (3) IL243117B2 (enExample)
LT (3) LT2457919T (enExample)
LU (1) LUC00290I2 (enExample)
NL (1) NL301210I2 (enExample)
NO (2) NO2457920T3 (enExample)
PL (3) PL2457919T3 (enExample)
PT (3) PT2121713E (enExample)
SI (2) SI2457920T1 (enExample)
WO (1) WO2008089403A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
WO2008013735A2 (en) * 2006-07-21 2008-01-31 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid
CA2675968C (en) 2007-01-18 2019-05-21 Genzyme Corporation Oligosaccharides comprising an aminooxy group and conjugates thereof
BRPI0815324A2 (pt) 2007-08-20 2015-07-14 Protalix Ltd "conjugado protêico que contém sacarídeos, processo de separação do conjugado protêico que contém sacarídeos, composição farmacêutica do conjugado protêico que contém sacarídeos, uso do conjugado protêico que contém sacarídeos e composto do conjugado protêico que contém sacarídeos"
SI2889043T1 (sl) 2008-12-16 2019-08-30 Genzyme Corporation Sintetične vmesne spojine za pripravo konjugatov oligosaharid-protein
ES2576853T3 (es) 2009-07-03 2016-07-11 Inserm - Institut National De La Santé Et De La Recherche Médicale Compuestos dirigidos al receptor del manosa 6-fosfato independiente de cationes
SG178051A1 (en) * 2009-07-27 2012-03-29 Lipoxen Technologies Ltd Glycopolysialylation of non-blood coagulation proteins
CN104530182A (zh) * 2009-07-27 2015-04-22 利普森技术有限公司 非凝血蛋白的糖基多唾液酸化
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
EP2585108A4 (en) * 2010-06-24 2016-04-13 Univ Kansas CONJUGATES WITH AN N-OXIM BINDING AND ASSOCIATED METHODS
WO2012082635A1 (en) * 2010-12-13 2012-06-21 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharide group a streptococcus
BR112013018516B1 (pt) 2011-01-20 2023-11-07 Protalix Ltd Construto de expressão de ácido nucleico, método de produção de uma proteína alfa-galactosidase humana recombinante, proteína alfagalactosidase humana, composição farmacêutica, e, uso de uma proteína alfagalactosidase humana ou de uma composição
US10017581B2 (en) 2013-02-20 2018-07-10 Valerion Therapeutics, Llc Methods and compositions for treatment of Pompe disease
GB201508025D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Fabry disease gene therapy
CA3010205A1 (en) 2015-12-30 2017-07-06 Amicus Therapeutics, Inc. Augmented acid alpha-glucosidase for the treatment of pompe disease
PT3624831T (pt) 2017-05-15 2023-07-04 Amicus Therapeutics Inc Alfa-glucosidase ácida humana recombinante
TWI821227B (zh) 2017-12-22 2023-11-11 美商健臻公司 胺甲喋呤誘發的免疫耐受性之生物標記
AU2019316103B2 (en) 2018-08-02 2026-02-19 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
US12018087B2 (en) 2018-08-02 2024-06-25 Dyne Therapeutics, Inc. Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
CN113260635B (zh) * 2018-11-08 2023-10-31 Dsm营养产品有限责任公司 寡糖组合物及其使用方法
WO2021156792A1 (en) 2020-02-07 2021-08-12 Novartis Ag Targeted plasma protein degradation
WO2021159092A1 (en) 2020-02-08 2021-08-12 Genzyme Corporation Compositions and methods for treating pompe disease
KR20230025874A (ko) 2020-06-14 2023-02-23 젠자임 코포레이션 후기 발병형 폼페병을 치료하기 위한 조성물 및 방법

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701521A (en) * 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
DE2940845B1 (de) 1979-10-09 1980-06-26 Ford Werke Ag Kreiselpumpendichtung,insbesondere fuer Kuehlwasserpumpen in Kraftfahrzeugen
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US5066789A (en) * 1988-09-30 1991-11-19 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
US5206370A (en) * 1989-02-24 1993-04-27 Johnson Matthey, Inc. Certain pyridyl hydrazines and hydrazides useful for protein labeling
IL93432A (en) 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) * 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5324663A (en) * 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US5583042A (en) * 1990-04-16 1996-12-10 Neose Pharmaceuticals, Inc. Apparatus for the synthesis of saccharide compositions
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
CA2073511A1 (en) * 1990-11-14 1992-05-29 Matthew R. Callstrom Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
WO1992016212A1 (en) * 1991-03-13 1992-10-01 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Increasing the therapeutic efficiency of macrophage-targeted therapeutic agents by up-regulating the mannose lectin on macrophages
JPH06506217A (ja) 1991-03-18 1994-07-14 エンゾン，インコーポレーテッド ポリペプチドまたはグリコポリペプチドとポリマーとのヒドラジン含有結合体
FR2721612B1 (fr) * 1994-06-23 1996-08-09 Idm Nouveaux dérivés d'oligosides, leur procédé de préparation et leurs applications.
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US6071890A (en) 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US6118045A (en) * 1995-08-02 2000-09-12 Pharming B.V. Lysosomal proteins produced in the milk of transgenic animals
AUPO190596A0 (en) * 1996-08-26 1996-09-19 Alchemia Pty Ltd Oligosaccharide synthesis
ATE451124T1 (de) * 1997-01-21 2009-12-15 Sanofi Pasteur Polysaccharid-peptid-konjugate
US5952516A (en) 1997-05-08 1999-09-14 Genzyme Corporation Cationic amphiphiles containing multiplesteroid lipophilic groups
WO2000009153A1 (en) 1997-10-29 2000-02-24 Genzyme Corporation Compositions and methods for treating lysosomal storage disease
US6287857B1 (en) 1998-02-09 2001-09-11 Genzyme Corporation Nucleic acid delivery vehicles
US6538117B1 (en) * 1999-08-10 2003-03-25 The Scripps Research Institute Programmable one-pot oligosaccharide synthesis
NZ509986A (en) * 1998-08-19 2003-10-31 Baxter Healthcare S Immunogenic beta-propionamido-linked polysaccharide and oligosaccharide protein conjugates as vaccines
US6399575B1 (en) * 1998-11-10 2002-06-04 Auburn University Methods and compositions for targeting compounds to the central nervous system
EP1035137A1 (en) * 1999-03-12 2000-09-13 Pasteur Merieux Serums Et Vaccins Method for the reductive amination of polysaccharides
CN1762990A (zh) * 1999-06-08 2006-04-26 拉卓拉药物公司 包含氨基氧基的化合价平台分子
US6534300B1 (en) * 1999-09-14 2003-03-18 Genzyme Glycobiology Research Institute, Inc. Methods for producing highly phosphorylated lysosomal hydrolases
US6770468B1 (en) * 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6749865B2 (en) * 2000-02-15 2004-06-15 Genzyme Corporation Modification of biopolymers for improved drug delivery
AU2001238346A1 (en) 2000-02-15 2001-08-27 Genzyme Corporation Modification of biopolymers for improved drug delivery
WO2002007671A2 (en) 2000-07-26 2002-01-31 Ramot-University Authority For Applied Research And Industrial Development Ltd. Intracellular delivery system for protein phosphatases and other polypeptides
CA2420183C (en) * 2000-08-18 2009-11-24 Massachusetts Institute Of Technology Apparatus and methods for the automated synthesis of oligosaccharides
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
US7001994B2 (en) * 2001-01-18 2006-02-21 Genzyme Corporation Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
US7560424B2 (en) * 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US7629309B2 (en) * 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
AU2002256423B2 (en) * 2001-04-30 2008-07-24 Zystor Therapeutics, Inc. Subcellular targeting of therapeutic proteins
JP2004514410A (ja) 2001-05-07 2004-05-20 スプラテック　ファーマ　インコーポレイティド 生物剤の経口およびｃｎｓ供給を強化するためのリガンド
EP2266968B1 (en) 2001-07-16 2013-01-09 Genzyme Corporation Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
US7265084B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
EP2305312B1 (en) 2001-10-10 2015-03-04 ratiopharm GmbH Remodelling and glycoconjugation of follicle-stimulating hormone (FSH)
AU2002348261A1 (en) 2001-11-26 2003-06-10 Genzyme Corporation Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
JP2006506317A (ja) 2002-01-11 2006-02-23 バイオマリン ファーマシューティカル インコーポレイテッド 治療用リソソーム酵素の送達のための酵素送達系としてのｐ９７の使用
TWI295483B (en) 2002-01-31 2008-04-01 Sumitomo Chemical Co 3-5 group compound semiconductor, process for producing the same, and compound semiconductor element using the same
EP1585817B1 (en) * 2002-02-20 2009-09-02 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
US6916802B2 (en) 2002-04-29 2005-07-12 Genzyme Corporation Amino ceramide-like compounds and therapeutic methods of use
RU2329274C2 (ru) 2002-09-11 2008-07-20 Фрезениус Каби Дойчланд Гмбх Способ получения производных гидроксиалкилкрахмала
EP1400533A1 (en) * 2002-09-11 2004-03-24 Fresenius Kabi Deutschland GmbH HASylated polypeptides, especially HASylated erythropoietin
WO2005002515A2 (en) 2003-06-20 2005-01-13 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
US20050026823A1 (en) * 2003-06-20 2005-02-03 Biomarin Pharmaceutical Inc. Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
JP2007501811A (ja) 2003-08-08 2007-02-01 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。
ATE374788T1 (de) 2003-08-12 2007-10-15 Lipoxen Technologies Ltd Polysialinsäurederivate
US7442372B2 (en) * 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
EP1525890A1 (en) 2003-10-02 2005-04-27 Complex Biosystems GmbH Protein-Proteophore complexes
US7176185B2 (en) * 2003-11-25 2007-02-13 Tsrl, Inc. Short peptide carrier system for cellular delivery of agent
EP1713508A2 (en) * 2004-01-29 2006-10-25 Biosynexus Incorporated Use of amino-oxy functional groups in the preparation of vaccine conjugates
EP1720405A4 (en) 2004-02-06 2008-08-27 Biomarin Pharm Inc PREPARATION OF STRONG PHOSPHORYLATED LYSOSOMAL ENZYMES AND THEIR USE
DK1740204T3 (en) 2004-04-01 2018-05-22 Chiesi Farm Spa MEDICAL USE OF ALFA MANNOSIDASE
US8017151B2 (en) * 2004-09-07 2011-09-13 Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center Amphiphilic polymer-protein conjugates and methods of use thereof
US7341720B2 (en) * 2005-04-06 2008-03-11 Genzyme Corporation Targeting of glycoprotein therapeutics
CA2675968C (en) * 2007-01-18 2019-05-21 Genzyme Corporation Oligosaccharides comprising an aminooxy group and conjugates thereof
WO2008089339A2 (en) 2007-01-18 2008-07-24 Genzyme Corporation Oligosaccharide conjugates for cellular targeting
SI2889043T1 (sl) * 2008-12-16 2019-08-30 Genzyme Corporation Sintetične vmesne spojine za pripravo konjugatov oligosaharid-protein

Similar Documents

Publication Publication Date Title
JP2017052962A5 (enExample)
JP2016503799A5 (enExample)
HRP20191562T1 (hr) Oligosaharidi koji sadrže aminooksi skupinu i njihovi konjugati
JP2020518627A5 (enExample)
JP2016514699A5 (enExample)
JP2019514877A5 (enExample)
JP2015534996A5 (enExample)
JP2016204383A5 (enExample)
JP2019513770A5 (enExample)
JP2021502388A5 (enExample)
JP2012515776A5 (enExample)
RU2010144823A (ru) Гетероциклические ингибиторы мек и способы их применения
JP2017535614A5 (enExample)
RU2017123807A (ru) Пиколинамиды с фунгицидной активностью
JP2017001031A5 (enExample)
SI2934145T1 (en) Histone demethylase inhibitors
JP2012528865A5 (enExample)
JP2013523756A5 (enExample)
RU2019103265A (ru) Способы получения 4-алкокси-3-(ацил или алкил)оксипиколинамидов
JP2019500374A5 (enExample)
JP2015044989A5 (enExample)
RU2018100967A (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
JP2018528282A5 (enExample)
JP2015127321A5 (enExample)
JP2017513885A5 (enExample)